Login / Signup

Uveal melanoma patient attitudes towards prognostic testing using gene expression profiling.

Basil K WilliamsJennifer J SiegelKatherina M AlsinaLauren JohnstonAmanda SiscoKyleigh LiPiraSara M SeligPeter G Hovland
Published in: Melanoma management (2022)
Most uveal melanoma patients desire prognostic testing and gain value from the GEP, independent of a high- or low-risk result.
Keyphrases
  • gene expression
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • case report
  • single cell
  • patient reported outcomes